• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON BD VENFLON¿ 2 PRO SAFETY SHIELDED IV CATHETER; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON BD VENFLON¿ 2 PRO SAFETY SHIELDED IV CATHETER; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 391454
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Unspecified Infection (1930)
Event Date 11/14/2017
Event Type  Injury  
Manufacturer Narrative
Date of event: unknown.The date received by manufacturer has been used for this field.The manufacturing location for this product is (b)(4).This site is not registered with the fda.Therefore the manufacturing site (b)(4) was used.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that a patient developed an infection after a bd venflon¿ 2 pro safety shielded iv catheter was inserted.Serious injury and medical intervention required.
 
Manufacturer Narrative
Investigation results: bd (b)(4) received 5 representative samples from the customer facility for investigation.The customer returned samples are intact and did not show any evidence of abnormality in package or product.Bd visually inspected 100 retain samples for any damage on the primary packaging, catheter & cannula tip for lot# 13l0141h.All samples found in ok condition.The team inspected the customer return samples, in which no any manufacturing defect observed in terms of package integrity, seal strength and sterility compromise.The team investigated the test records of customer reported lot number, the product conform to sterility specification.The team also checked the seal strength of the unit pack performed in routine testing, the results were acceptable and conforms to specification limit of the product.The defect is not confirmed.The complaint history for the lot# 13l0141h was reviewed and till date no complaint had been registered against the above lot in terms of package integrity and sterility compromise which may cause reaction / phlebitis.Dhr was reviewed for the product test.The entire routing test for reported lot found within the specification limit.No discrepancy was reported and recorded in dhr in customer reported lot # 13l0141h.Log sheet ¿ printing shifting problem is recorded in packaging process during manufacturing of lot 13l0141h.Stoppages ¿ station 21 proximity sensor problem & cannula orientation problem stoppages occurred in va assembly process during manufacturing of lot # 13l0141h.Others ¿ lot 13l0141h was sterilized in sterilization cycle# 13111121 (sterilization process parameter, product sterility test report & biological indicator sterility test report attached), no discrepancy observed during the sterilization process.Conclusion: the exact root cause is not identified.Based on an evaluation of severity and occurrence, it was determined that no corrective action is required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD VENFLON¿ 2 PRO SAFETY SHIELDED IV CATHETER
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BECTON DICKINSON
1 becton drive
franklin lakes NJ 07417
Manufacturer (Section G)
BECTON DICKINSON
1 becton drive
franklin lakes NJ 07417
Manufacturer Contact
brett wilko
9450 south state street
sandy, UT 84070
8015652845
MDR Report Key7097394
MDR Text Key94194566
Report Number2243072-2017-00380
Device Sequence Number1
Product Code FOZ
Combination Product (y/n)N
Reporter Country CodeRO
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 01/25/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/07/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Device Expiration Date10/31/2018
Device Catalogue Number391454
Device Lot Number13L0141H
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/21/2017
Is the Reporter a Health Professional? No
Date Manufacturer Received11/14/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/11/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-